Viewing data from:

PIMECROLIMUS

ANDA

PIMECROLIMUS | A211769 | GLENMARK PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: ELIDEL(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$3.43

per gm

Lowest NADAC/Unit

$3.15

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
68462060994PIMECROLIMUS 1% CREAM	$3.43	GM	Generic	—	2026-06-17
68462060935PIMECROLIMUS 1% CREAM	$3.31	GM	Generic	—	2026-06-17
68462060965PIMECROLIMUS 1% CREAM	$3.15	GM	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs

6 active API suppliers hold Drug Master Files for this ingredient.

BIOCON LTDPIMECROLIMUS USP

DMF 293902015

BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTDPIMECROLIMUS INTERMEDIATE ASCOMYCIN

DMF 294332015

MEDICHEM SAPIMECROLIMUS (MED 201445/E)

DMF 294812015

CONCORD BIOTECH LTDPIMECROLIMUS USP

DMF 296582015

BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTDPIMECROLIMUS (NON-STERILE, API)

DMF 300902015

CURIA ITALY SRLPIMECROLIMUS

DMF 323482017

CHENGDU YACHT BIOTECHNOLOGY CO LTDPIMECROLIMUS

DMF 419462025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1%

0 patents0 exclusivities▴

CREAM;TOPICAL | Approved: Aug 29, 2019

No patent or exclusivity listings for this strength.